FIELD: chemistry.
SUBSTANCE: present invention relates to a novel compound of formula (I) or a pharmaceutically acceptable salt or isomer thereof. In the compound of formula (I), X is C or N, Y is C, N, C = O or C-halogen, Z is C or N, Q is O or NH, W is C, N, C1-C6 alkyl or C-halogen, and the remaining symbols and radicals are as defined in the claims. Compound of formula (I) has GPR40 receptor agonist activity, enhances insulin secretion and inhibits blood sugar rise after glucose loading. Invention also relates to a pharmaceutical composition containing said compound as an active ingredient. 
EFFECT: compound is suitable for treating diabetes and its complications.
10 cl, 1 tbl, 232 ex
формула (I) - formula (I)
| Title | Year | Author | Number |
|---|---|---|---|
| SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS, METHODS OF PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE AGENT | 2014 |
|
RU2654483C2 |
| INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
| GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
| INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
| SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST, METHOD OF ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN ACTIVE INGREDIENT | 2020 |
|
RU2798605C1 |
| QUINAZOLINE DERIVATIVES FOR SLOWING DOWN GROWTH OF CANCER CELLS AND METHOD OF OBTAINING THEM | 2005 |
|
RU2362773C2 |
| THIENO[3,2-d]PYRIMIDINE DERIVATIVES WITH PROTEIN KINASE INHIBITORY ACTIVITY | 2012 |
|
RU2705577C2 |
| ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
| NEW AMINOARYL DERIVATIVE SUITABLE AS A DIACYLGLYCEROLACYL TRANSFERASE 2 INHIBITOR AND ITS APPLICATION | 2020 |
|
RU2799819C1 |
| CYTOSKELETALLY ACTIVE RHO-KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND USE THEREOF | 2007 |
|
RU2470928C2 |
